Vapotherm Access is dedicated to improving patient quality of life, and lowering costs for respiratory distress patients.
Improving Patient Quality of Life
98% of patients studied agree that daily symptom reporting helped them better understand and manage their COPD.
91% of patients studied said Vapotherm Access helped avoid or reduce the need to go to the Emergency Room or Urgent Care.
85% of patients studied reported improved quality of life.
"It was the first time in years that I didn't feel alone. Absolutely invaluable."
- MARGIE BOTT, A PATIENT ON VAPOTHERM ACCESS
64% symptom exacerbation rate reduction in studied patients after 1 month on-service.
This reduction can save patients and payers thousands of dollars when an exacerbation can cost ~$7,100 and intubation up to $88,000 depending on length of stay.
41% all-cause reduction in studied patients in annual inpatient admissions and Emergency Department visits.
COPD is a chronic and progressive disease - there is no cure. Frequent exacerbations, mainly in patients with severe COPD, accelerate disease progression and mortality which is why it's important for COPD patients to avoid hospitalizations.
"Our goal is for every patient to feel empowered and to not live in fear of a possible exacerbation or lack of access to care. We make sure every patient's question is answered and that they never feel like a burden asking for help."
- Heather Markus, Vice President of Vapotherm Access